(INGR) Ingredion - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4571871023

Starches, Sweeteners, Corn Oil, Gluten Feed, Biomaterials

INGR EPS (Earnings per Share)

EPS (Earnings per Share) of INGR over the last years for every Quarter: "2020-09": 1.77, "2020-12": 1.75, "2021-03": 1.85, "2021-06": 2.05, "2021-09": 1.67, "2021-12": 1.09, "2022-03": 1.95, "2022-06": 2.12, "2022-09": 1.73, "2022-12": 1.65, "2023-03": 2.8, "2023-06": 2.32, "2023-09": 2.33, "2023-12": 1.97, "2024-03": 2.08, "2024-06": 2.87, "2024-09": 3.05, "2024-12": 2.63, "2025-03": 2.97, "2025-06": 2.87, "2025-09": 2.75,

INGR Revenue

Revenue of INGR over the last years for every Quarter: 2020-09: 1502, 2020-12: 1593, 2021-03: 1614, 2021-06: 1762, 2021-09: 1763, 2021-12: 1755, 2022-03: 1892, 2022-06: 2044, 2022-09: 2023, 2022-12: 1987, 2023-03: 2137, 2023-06: 2069, 2023-09: 2033, 2023-12: 1921, 2024-03: 1882, 2024-06: 1878, 2024-09: 1870, 2024-12: 1800, 2025-03: 1813, 2025-06: 1833, 2025-09: 1816,
Risk via 10d forecast
Volatility 19.5%
Value at Risk 5%th 29.9%
Reward
Sharpe Ratio -1.58
Alpha Jensen -39.13
Character
Hurst Exponent 0.525
Beta 0.706
Drawdowns 3y
Max DD 29.56%
Mean DD 7.29%

Description: INGR Ingredion November 03, 2025

Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, cosmetics, and specialty industrial markets worldwide. Its product set spans everything from glucose syrups and high-fructose corn syrup to specialty starches for biodegradable plastics and water-filtration applications.

Key metrics and sector drivers: In fiscal 2023 the company generated roughly $6.5 billion in revenue with an adjusted EBITDA margin near 10 %, reflecting strong pricing power in high-growth “clean-label” and plant-based food segments. Ingredient demand is closely tied to corn commodity prices and global food-security trends, while end-market exposure to the expanding snack-and-convenience sector underpins volume growth. Additionally, Ingredion’s recent acquisitions in the specialty bioplastics space aim to capture a projected $45 billion market opportunity by 2030.

For a deeper quantitative view of INGR’s valuation and risk profile, you may find the ValueRay platform useful.

INGR Stock Overview

Market Cap in USD 6,911m
Sub-Industry Agricultural Products & Services
IPO / Inception 1997-12-11
Return 12m vs S&P 500 -36.3%
Analyst Rating 3.43 of 5

INGR Dividends

Dividend Yield 2.98%
Yield on Cost 5y 4.80%
Yield CAGR 5y -1.82%
Payout Consistency 97.7%
Payout Ratio 28.7%

INGR Growth Ratios

CAGR 7.70%
CAGR/Max DD Calmar Ratio 0.26
CAGR/Mean DD Pain Ratio 1.06
Current Volume 696.6k
Average Volume 539.5k

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (659.0m TTM) > 0 and > 6% of Revenue (6% = 435.7m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA -4.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 30.82% (prev 27.76%; Δ 3.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 975.0m > Net Income 659.0m (YES >=105%, WARN >=100%)
Net Debt (883.0m) to EBITDA (1.18b) ratio: 0.75 <= 3.0 (WARN <= 3.5)
Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (65.4m) change vs 12m ago -1.65% (target <= -2.0% for YES)
Gross Margin 25.43% (prev 23.07%; Δ 2.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 94.57% (prev 100.3%; Δ -5.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 25.84 (EBITDA TTM 1.18b / Interest Expense TTM 37.0m) >= 6 (WARN >= 3)

Altman Z'' 6.34

(A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.28b) / Total Assets 7.83b
(B) 0.70 = Retained Earnings (Balance) 5.50b / Total Assets 7.83b
(C) 0.12 = EBIT TTM 956.0m / Avg Total Assets 7.68b
(D) 1.28 = Book Value of Equity 4.55b / Total Liabilities 3.57b
Total Rating: 6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.82

1. Piotroski 6.50pt = 1.50
2. FCF Yield 10.84% = 5.0
3. FCF Margin 11.62% = 2.91
4. Debt/Equity 0.42 = 2.41
5. Debt/Ebitda 0.75 = 2.08
6. ROIC - WACC (= 4.78)% = 5.97
7. RoE 16.10% = 1.34
8. Rev. Trend -88.16% = -6.61
9. EPS Trend 64.44% = 3.22

What is the price of INGR shares?

As of November 13, 2025, the stock is trading at USD 108.17 with a total of 696,604 shares traded.
Over the past week, the price has changed by +0.44%, over one month by -9.90%, over three months by -14.15% and over the past year by -26.22%.

Is Ingredion a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Ingredion (NYSE:INGR) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 67.82 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INGR is around 96.02 USD . This means that INGR is currently overvalued and has a potential downside of -11.23%.

Is INGR a buy, sell or hold?

Ingredion has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold INGR.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the INGR price?

Issuer Target Up/Down from current
Wallstreet Target Price 124.3 14.9%
Analysts Target Price 124.3 14.9%
ValueRay Target Price 105.5 -2.4%

INGR Fundamental Data Overview November 11, 2025

Market Cap USD = 6.91b (6.91b USD * 1.0 USD.USD)
P/E Trailing = 10.8058
P/E Forward = 10.0503
P/S = 0.9516
P/B = 1.807
P/EG = 1.3311
Beta = 0.706
Revenue TTM = 7.26b USD
EBIT TTM = 956.0m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.79b USD (from longTermDebt, last fiscal year)
Short Term Debt = 57.0m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 883.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.79b USD (6.91b + Debt 1.80b - CCE 921.0m)
Interest Coverage Ratio = 25.84 (Ebit TTM 956.0m / Interest Expense TTM 37.0m)
FCF Yield = 10.84% (FCF TTM 844.0m / Enterprise Value 7.79b)
FCF Margin = 11.62% (FCF TTM 844.0m / Revenue TTM 7.26b)
Net Margin = 9.07% (Net Income TTM 659.0m / Revenue TTM 7.26b)
Gross Margin = 25.43% ((Revenue TTM 7.26b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 25.06% (prev 26.02%)
Tobins Q-Ratio = 0.99 (Enterprise Value 7.79b / Total Assets 7.83b)
Interest Expense / Debt = 0.39% (Interest Expense 7.00m / Debt 1.80b)
Taxrate = 28.63% (69.0m / 241.0m)
NOPAT = 682.3m (EBIT 956.0m * (1 - 28.63%))
Current Ratio = 2.75 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.42 (Debt 1.80b / totalStockholderEquity, last quarter 4.24b)
Debt / EBITDA = 0.75 (Net Debt 883.0m / EBITDA 1.18b)
Debt / FCF = 1.05 (Net Debt 883.0m / FCF TTM 844.0m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.41% (Net Income 659.0m / Total Assets 7.83b)
RoE = 16.10% (Net Income TTM 659.0m / Total Stockholder Equity 4.09b)
RoCE = 16.26% (EBIT 956.0m / Capital Employed (Equity 4.09b + L.T.Debt 1.79b))
RoIC = 11.67% (NOPAT 682.3m / Invested Capital 5.84b)
WACC = 6.90% (E(6.91b)/V(8.71b) * Re(8.62%) + D(1.80b)/V(8.71b) * Rd(0.39%) * (1-Tc(0.29)))
Discount Rate = 8.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.76%
[DCF Debug] Terminal Value 72.22% ; FCFE base≈969.2m ; Y1≈774.5m ; Y5≈524.6m
Fair Price DCF = 138.2 (DCF Value 8.81b / Shares Outstanding 63.7m; 5y FCF grow -24.05% → 3.0% )
EPS Correlation: 64.44 | EPS CAGR: 20.41% | SUE: -0.80 | # QB: 0
Revenue Correlation: -88.16 | Revenue CAGR: -3.22% | SUE: -2.09 | # QB: 0

Additional Sources for INGR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle